Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

Quarterly Net Profit at Rs. 119.50 crore in March 2025 down 12.52% from Rs. 136.60 crore in March 2024. EBITDA stands at Rs.

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The latest health news highlights Sanofi's $20 billion U.S. investment through 2030, Merck's cancer drug expansion and the ...

Sanofi India's EBITDA rose 25% to ₹171.9 crore in Q4, with margins improving to 32.1%. Shares closed 2.3% higher at ₹6,066.55 ...

Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...

(Reuters) -French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through ...